Liang‐Chuan S. Wang

2.6k total citations · 3 hit papers
21 papers, 2.2k citations indexed

About

Liang‐Chuan S. Wang is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Liang‐Chuan S. Wang has authored 21 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Liang‐Chuan S. Wang's work include Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (5 papers) and CAR-T cell therapy research (4 papers). Liang‐Chuan S. Wang is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (5 papers) and CAR-T cell therapy research (4 papers). Liang‐Chuan S. Wang collaborates with scholars based in United States, New Zealand and France. Liang‐Chuan S. Wang's co-authors include Steven Μ. Albelda, Veena Kapoor, Carl H. June, Edmund K. Moon, Albert Lo, Jing Sun, John Scholler, Ellen Puré, Amy C. Durham and Jarrod D. Predina and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Clinical Cancer Research.

In The Last Decade

Liang‐Chuan S. Wang

21 papers receiving 2.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity

2013 515 citations Liang‐Chuan S. Wang, Albert Lo et al. Cancer Immunology Research profile →
Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor

2011 447 citations Edmund K. Moon, Carmine Carpenito et al. Clinical Cancer Research profile →
Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells

2015 407 citations Albert Lo, Liang‐Chuan S. Wang et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liang‐Chuan S. Wang United States	15	1.7k	949	637	406	393	21	2.2k
Dhanalakshmi Chinnasamy United States	16	1.6k 0.9×	1.0k 1.1×	778 1.2×	371 0.9×	580 1.5×	25	2.2k
Clare Y. Slaney Australia	23	1.8k 1.1×	1.2k 1.3×	761 1.2×	434 1.1×	304 0.8×	38	2.6k
Bizhi Shi China	28	1.7k 1.0×	1.0k 1.1×	914 1.4×	460 1.1×	305 0.8×	53	2.6k
Kheng Newick United States	14	1.9k 1.1×	897 0.9×	819 1.3×	608 1.5×	445 1.1×	15	2.4k
Evripidis Lanitis Switzerland	19	1.6k 0.9×	887 0.9×	695 1.1×	562 1.4×	367 0.9×	25	2.2k
Liza B. John Australia	16	1.7k 1.0×	1.2k 1.3×	612 1.0×	389 1.0×	399 1.0×	27	2.4k
Whitney L. Gladney United States	14	1.8k 1.1×	1.2k 1.2×	584 0.9×	415 1.0×	261 0.7×	24	2.4k
Stefanie R. Bailey United States	19	1.6k 1.0×	1.1k 1.2×	699 1.1×	468 1.2×	383 1.0×	35	2.3k
Carmen S. Yong Australia	12	1.2k 0.7×	848 0.9×	455 0.7×	303 0.7×	313 0.8×	21	1.7k
Christel Devaud Australia	16	1.4k 0.8×	1.0k 1.1×	441 0.7×	292 0.7×	322 0.8×	27	1.9k

Countries citing papers authored by Liang‐Chuan S. Wang

Since Specialization

Citations

This map shows the geographic impact of Liang‐Chuan S. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang‐Chuan S. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang‐Chuan S. Wang more than expected).

Fields of papers citing papers by Liang‐Chuan S. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang‐Chuan S. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang‐Chuan S. Wang. The network helps show where Liang‐Chuan S. Wang may publish in the future.

Co-authorship network of co-authors of Liang‐Chuan S. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Liang‐Chuan S. Wang. A scholar is included among the top collaborators of Liang‐Chuan S. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang‐Chuan S. Wang. Liang‐Chuan S. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moon, Edmund K., Liang‐Chuan S. Wang, Rachel C. Lynn, et al.. (2017). Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines. OncoImmunology. 7(3). e1395997–e1395997. 140 indexed citations

Lo, Albert, Liang‐Chuan S. Wang, John Scholler, et al.. (2015). Tumor-Promoting Desmoplasia Is Disrupted by Depleting FAP-Expressing Stromal Cells. Cancer Research. 75(14). 2800–2810. 407 indexed citations breakdown →

Liu, Yuhong, Claire E. O’Leary, Liang‐Chuan S. Wang, et al.. (2015). CD11b+Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesis. OncoImmunology. 5(1). e1061175–e1061175. 32 indexed citations

Xiao, Haiyan, Jing Jiao, Liqing Wang, et al.. (2015). HDAC5 controls the functions of Foxp3⁺ T‐regulatory and CD8⁺ T cells. International Journal of Cancer. 138(10). 2477–2486. 62 indexed citations

Koblish, Holly K., Michael Hansbury, Liang‐Chuan S. Wang, et al.. (2015). Abstract 1336: Novel immunotherapeutic activity of JAK and PI3Kδ inhibitors in a model of pancreatic cancer. Cancer Research. 75(15_Supplement). 1336–1336. 8 indexed citations

Wang, Liang‐Chuan S., Albert Lo, John Scholler, et al.. (2013). Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity. Cancer Immunology Research. 2(2). 154–166. 515 indexed citations breakdown →

Riese, Matthew J., Liang‐Chuan S. Wang, Edmund K. Moon, et al.. (2013). Enhanced Effector Responses in Activated CD8+ T Cells Deficient in Diacylglycerol Kinases. Cancer Research. 73(12). 3566–3577. 106 indexed citations

Moon, Edmund K., Carmine Carpenito, Jing Sun, et al.. (2011). Expression of a Functional CCR2 Receptor Enhances Tumor Localization and Tumor Eradication by Retargeted Human T cells Expressing a Mesothelin-Specific Chimeric Antibody Receptor. Clinical Cancer Research. 17(14). 4719–4730. 447 indexed citations breakdown →

Sun, Jing, Liang‐Chuan S. Wang, Zvi G. Fridlender, et al.. (2011). Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulation. Biochemical Pharmacology. 82(9). 1175–1185. 14 indexed citations

10.

Wang, Liang‐Chuan S., Rachel C. Lynn, Guanjun Cheng, et al.. (2011). Treating Tumors With a Vaccinia Virus Expressing IFNβ Illustrates the Complex Relationships Between Oncolytic Ability and Immunogenicity. Molecular Therapy. 20(4). 736–748. 40 indexed citations

11.

Fridlender, Zvi G., Veena Kapoor, George Buchlis, et al.. (2010). Monocyte Chemoattractant Protein–1 Blockade Inhibits Lung Cancer Tumor Growth by Altering Macrophage Phenotype and Activating CD8+ Cells. American Journal of Respiratory Cell and Molecular Biology. 44(2). 230–237. 124 indexed citations

12.

Ching, Lai‐Ming, et al.. (2010). Abstract 24: Labeling of oxidizable proteins with a photoactivatable analog of the antitumor agent DMXAA and evidence for redox signaling in its mode of action. Cancer Research. 70(8_Supplement). 24–24. 3 indexed citations

13.

Cheng, Guanjun, Jing Sun, Zvi G. Fridlender, et al.. (2010). Activation of the Nucleotide Oligomerization Domain Signaling Pathway by the Non-bacterially Derived Xanthone Drug 5′6-Dimethylxanthenone-4-acetic Acid (Vadimezan). Journal of Biological Chemistry. 285(14). 10553–10562. 17 indexed citations

14.

Wang, Liang‐Chuan S., See‐Tarn Woon, Kimiora Henare, et al.. (2010). Labeling of Oxidizable Proteins with a Photoactivatable Analog of the Antitumor Agent DMXAA: Evidence for Redox Signaling in Its Mode of Action. Neoplasia. 12(9). 755–IN3. 9 indexed citations

15.

Fridlender, Zvi G., George Buchlis, Veena Kapoor, et al.. (2009). CCL2 Blockade Augments Cancer Immunotherapy. Cancer Research. 70(1). 109–118. 151 indexed citations

16.

Wang, Liang‐Chuan S., Lotte Thomsen, R. M. Sutherland, et al.. (2009). Neutrophil Influx and Chemokine Production during the Early Phases of the Antitumor Response to the Vascular Disrupting Agent DMXAA (ASA404). Neoplasia. 11(8). 793–803. 39 indexed citations

17.

Palmer, Brian D., Kimiora Henare, See‐Tarn Woon, et al.. (2007). Synthesis and Biological Activity of Azido Analogues of 5,6-Dimethylxanthenone-4-acetic Acid for Use in Photoaffinity Labeling. Journal of Medicinal Chemistry. 50(16). 3757–3764. 19 indexed citations

18.

Wang, Liang‐Chuan S., See‐Tarn Woon, Bruce C. Baguley, & Lai-Ming Ching. (2006). Inhibition of DMXAA-Induced Tumor Necrosis Factor Production in Murine Splenocyte Cultures by NF-κB Inhibitors. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 16(1). 1–14. 12 indexed citations

19.

Chung, Francisco, Liang‐Chuan S. Wang, Philip Kestell, Bruce C. Baguley, & Lai‐Ming Ching. (2004). Modulation of thalidomide pharmacokinetics by cyclophosphamide or 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mice: the role of tumour necrosis factor. Cancer Chemotherapy and Pharmacology. 53(5). 377–383. 10 indexed citations

20.

Wang, Liang‐Chuan S., et al.. (2003). Induction of tumour necrosis factor and interferon-γ in cultured murine splenocytes by the antivascular agent DMXAA and its metabolites. Biochemical Pharmacology. 67(5). 937–945. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact